ACCRUED EXPENSES

9 Months Ended

Mar. 31, 2017

Accrued Expenses

ACCRUED EXPENSES

Accrued expenses consist of the following:

	March 31, 2017		June 30, 2016
Bremelanotide program costs	$	7,739,920	$	6,983,581
Other research related expenses		237,841		69,609
Professional services		78,751		231,482
Other		260,180		483,061
	$	8,316,692	$	7,767,733